|
FDA Warns Epimed International for Supplier Control, Procedural Issues
Lax process and quality control of supplied components helped land Irving, Texas-based Epimed International an FDA warning letter. Following a May 1 to 17 inspection of the company’s Johnstown, N.Y., plant, the FDA recounted flaws in the company’s supplier quality process, including a failure to establish and maintain procedures for accepting incoming products.
Devices & Diagnostics Letter |
|
Register Now
Archives